Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of PF-04360365 in mild to moderate Alzheimer's disease
2009-011172-30Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing PF-04360365 with Placebo (2 arms). Primary endpoints: Safety and tolerability, Pharmacokinetics and 1 more. Started Jun 2009; status: completed.
02
Drugs
ponezumab
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2009-011172-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011172-30.